000 | 01903 a2200601 4500 | ||
---|---|---|---|
005 | 20250514221435.0 | ||
264 | 0 | _c20050411 | |
008 | 200504s 0 0 eng d | ||
022 | _a0017-5749 | ||
024 | 7 |
_a10.1136/gut.2004.043554 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGustot, T | |
245 | 0 | 0 |
_aProfile of soluble cytokine receptors in Crohn's disease. _h[electronic resource] |
260 |
_bGut _cApr 2005 |
||
300 |
_a488-95 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntigens, CD _xblood |
650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
650 | 0 | 4 |
_aColitis, Ulcerative _ximmunology |
650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
650 | 0 | 4 | _aCytokine Receptor gp130 |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Mucosal |
650 | 0 | 4 | _aInfliximab |
650 | 0 | 4 |
_aInterleukin-6 _xblood |
650 | 0 | 4 |
_aIntestinal Mucosa _ximmunology |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Glycoproteins _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aReceptors, Cytokine _xblood |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aTissue Culture Techniques |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aLemmers, A | |
700 | 1 | _aLouis, E | |
700 | 1 | _aNicaise, C | |
700 | 1 | _aQuertinmont, E | |
700 | 1 | _aBelaiche, J | |
700 | 1 | _aRoland, S | |
700 | 1 | _aVan Gossum, A | |
700 | 1 | _aDevière, J | |
700 | 1 | _aFranchimont, D | |
773 | 0 |
_tGut _gvol. 54 _gno. 4 _gp. 488-95 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.2004.043554 _zAvailable from publisher's website |
999 |
_c15427042 _d15427042 |